Documents
Application Sponsors
ANDA 076723 | NOSTRUM LABS INC | |
Marketing Status
Application Products
001 | TABLET;ORAL | 8MG | 0 | HYDROMORPHONE HYDROCHLORIDE | HYDROMORPHONE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2005-10-18 | |
LABELING; Labeling | SUPPL | 6 | AP | 2020-04-15 | STANDARD |
REMS; REMS | SUPPL | 8 | AP | 2018-09-18 | |
LABELING; Labeling | SUPPL | 9 | AP | 2020-04-15 | STANDARD |
LABELING; Labeling | SUPPL | 10 | AP | 2020-04-15 | STANDARD |
LABELING; Labeling | SUPPL | 11 | AP | 2020-04-15 | STANDARD |
Submissions Property Types
SUPPL | 6 | Null | 15 |
SUPPL | 8 | Null | 15 |
SUPPL | 9 | Null | 7 |
SUPPL | 10 | Null | 7 |
SUPPL | 11 | Null | 7 |
TE Codes
CDER Filings
NOSTRUM LABS INC
cder:Array
(
[0] => Array
(
[ApplNo] => 76723
[companyName] => NOSTRUM LABS INC
[docInserts] => ["",""]
[products] => [{"drugName":"HYDROMORPHONE HYDROCHLORIDE","activeIngredients":"HYDROMORPHONE HYDROCHLORIDE","strength":"8MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"HYDROMORPHONE HYDROCHLORIDE","submission":"HYDROMORPHONE HYDROCHLORIDE","actionType":"8MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)